The Allosteric Activation of α7 nAChR by α-Conotoxin MrIC Is Modified by Mutations at the Vestibular Site

• Published in: Toxins Vol. 13; no. 8; p. 555
• Main Authors: Gulsevin, Alican, Papke, Roger L, Stokes, Clare, Tran, Hue N T, Jin, Aihua H, Vetter, Irina, Meiler, Jens
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 10.08.2021; MDPI
• Subjects: Acetylcholine receptors (nicotinic); allosteric activation; Allosteric properties; Allosteric Regulation - drug effects; alpha7 Nicotinic Acetylcholine Receptor - chemistry; alpha7 Nicotinic Acetylcholine Receptor - genetics; alpha7 Nicotinic Acetylcholine Receptor - metabolism; Alzheimer's disease; Amino acids; Animals; Binding Sites; Conotoxins; Conotoxins - pharmacology; Electrophysiology; Female; Hydrogen bonds; Hypotheses; Ligands; Mode of action; Molecular Docking Simulation; Mutation; Oocytes; peptide docking; Peptides; Proteins; Receptors; Toxins; venom peptide; Vestibular system; Vestibules; Xenopus laevis; α-conotoxin MrIC; α7 nAChR; peptide docking; α-conotoxin MrIC; venom peptide; allosteric activation; α7 nAChR
• ISSN: 2072-6651; 2072-6651
• DOI: 10.3390/toxins13080555

α-conotoxins are 13-19 amino acid toxin peptides that bind various nicotinic acetylcholine receptor (nAChR) subtypes. α-conotoxin Mr1.7c (MrIC) is a 17 amino acid peptide that targets α7 nAChR. Although MrIC has no activating effect on α7 nAChR when applied by itself, it evokes a large response when co-applied with the type II positive allosteric modulator PNU-120596, which potentiates the α7 nAChR response by recovering it from a desensitized state. A lack of standalone activity, despite activation upon co-application with a positive allosteric modulator, was previously observed for molecules that bind to an extracellular domain allosteric activation (AA) site at the vestibule of the receptor. We hypothesized that MrIC may activate α7 nAChR allosterically through this site. We ran voltage-clamp electrophysiology experiments and in silico peptide docking calculations in order to gather evidence in support of α7 nAChR activation by MrIC through the AA site. The experiments with the wild-type α7 nAChR supported an allosteric mode of action, which was confirmed by the significantly increased MrIC + PNU-120596 responses of three α7 nAChR AA site mutants that were designed in silico to improve MrIC binding. Overall, our results shed light on the allosteric activation of α7 nAChR by MrIC and suggest the involvement of the AA site.